Nalbuphine Hci Injection, Solution
Product Images NDC 51662-1418

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Nalbuphine Hci (NDC 51662-1418). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton Labeling (Box Labeling)

Packaging label for Nalbuphine HCl Injection 20 mg/mL, a 10 mL multi-dose fliptop vial. The label includes storage instructions to protect from light and use via intravenous, intramuscular, or subcutaneous routes. The labeler is Hospira, Inc., with address in Lake Forest, IL. The label also shows composition and usage instructions.*

FDA Label Image

Boxed Warning (Boxed Warning)

The image shows a drug safety warning panel for Nalbuphine Hydrochloride Injection. It highlights life-threatening respiratory depression risks and dangers from concomitant use with benzodiazepines or other CNS depressants. The panel advises monitoring for respiratory depression and cautions on use with opioids and CNS depressants, including alcohol. It includes recommendations to reserve such prescribing for patients lacking alternative options, limit dosages, and monitor for symptoms.*

FDA Label Image

How Supplied (How Supplied)

A data table listing various nalbuphine hydrochloride injection strengths and packaging configurations by NDC. It details units of sale ranging from single-dose 1 mL ampuls in trays of 10 to multiple-dose 10 mL fliptop vials in cases of 25, with concentrations from 10 mg/mL to 20 mg/mL and total amounts per vial up to 200 mg/10 mL.*

FDA Label Image

Logo (Logo)

FDA Label Image

Serialized Carton Labeling (Serialized Box Labeling)

Packaging label for Nalbuphine HCl Injection 20 mg/mL in a 10 mL multi-dose fliptop vial. The label indicates the injectable solution for intravenous, intramuscular, and subcutaneous use. The label includes Rx only designation, with the Hospira logo visible, and references a distributor named HF Acquisition Co LLC.*

FDA Label Image

Structure (Structure)

Chemical structure of Nalbuphine HCl, showing the detailed molecular arrangement including hydroxyl groups, nitrogen atoms, and cycloalkane rings.*

FDA Label Image

Vial Labeling (Vial Labeling)

Label for NALBUPHINE HCI injection, 20 mg/mL, a multiple-dose 10 mL vial. It is indicated for intravenous, intramuscular, or subcutaneous use. The label shows the manufacturer Hospira, Inc., Lake Forest, IL. It includes formulation details, storage instructions, and the NDC code 0409-1467-01.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.